Heavy Menstrual Bleeding Treatment With a Levonorgestrel 52-mg Intrauterine Device

To evaluate heavy menstrual bleeding treatment outcomes with levonorgestrel 52-mg intrauterine device (IUD) use in participants without body mass index (BMI) or parity restrictions. METHODS: Investigators included participants aged 18–50 years with no pelvic or systemic pathology causing heavy menst...

Descripción completa

Detalles Bibliográficos
Autores principales: Creinin, Mitchell D., Barnhart, Kurt T., Gawron, Lori M., Eisenberg, David, Mabey, R. Garn, Jensen, Jeffrey T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108838/
https://www.ncbi.nlm.nih.gov/pubmed/37023455
http://dx.doi.org/10.1097/AOG.0000000000005137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108838/
https://www.ncbi.nlm.nih.gov/pubmed/37023455
http://dx.doi.org/10.1097/AOG.0000000000005137

Ejemplares similares